DID YOU KNOW THAT 31% OF PEOPLE WERE 50 YEARS OR OLDER AT THE TIME OF THEIR HIV DIAGNOSIS?
 
 
DID YOU KNOW THAT OF THE NEW HIV DIAGNOSES, ONLY 54% WERE MEN WHO HAD SEX WITH MEN?

WHEN TO PERFORM HIV TESTING

 
 
Healthcare professionals are encouraged to offer HIV testing to patients presenting with HIV indicator conditions.
 
Additionally, HIV testing is recommended for individuals with specific risk factors for HIV infection, including men and transgender individuals who engage in sexual activity with men, individuals with multiple sexual partners who do not consistently use condoms, people who inject drugs, persons originating from, or with partners from, regions with a high prevalence of HIV, recipients of unscreened blood or donor products, sex workers, and the sexual partners of individuals within these high-risk categories
It is noteworthy that HIV tests can reliably detect an HIV infection six weeks post-exposure. Testing conducted within the first six weeks after a high-risk exposure may yield a false-negative result. In such cases, it is advisable to repeat the HIV test at a later date to confirm the diagnosis.
 
Moreover, a follow-up test is strongly recommended when an initial test result is negative, but clinical suspicion of HIV infection persists, particularly six weeks or longer after the potential exposure.
 

DISCOVER WHEN TESTING FOR HIV IS RECOMMENDED

 

24

Conditions

AIDS-DEFINING CONDITIONS

HIV testing is strongly recommended

 

Neoplasm

  • Cervical cancer
  • Non-Hodgkin lymphoma
  • Kaposi's sarcoma

Bacterial infections

  • Mycobacterium tuberculosis (pulmonary or extrapulmonary)
  • Mycobacterium avium complex (MAC) (disseminated or extrapulmonary)
  • Mycobacterium kansasii (disseminated or extrapulmonary)
  • Mycobacterium, other species or unidentified species (disseminated or extrapulmonary)
  • Pneumonia, recurrent (2 or more episodes in 12 months)
  • Salmonella sepsis

Viral infections

  • Cytomegalovirus retinitis
  • Cytomegalovirus (except liver, spleen and glands)
  • Herpes simplex ulcers (lasting more than 1 month), bronchitis or pneumonitis
  • Progressive multifocal leukoencephalopathy (PML)

Parasitic infections

  • Cerebral toxoplasmosis
  • Cryptosporidiosis (diarrhea lasting more than 1 month)
  • Isosporiasis (lasting more than 1 month)
  • Atypical disseminated leishmaniasis
  • Reactivation of American trypanosomiasis (Chagas disease)

Fungal infections

  • Pneumocystis carinii pneumonia (PCP)
  • Candida esophagitis
  • Candida, bronchial, tracheal, pulmonary
  • Cryptococcosis (extrapulmonary)
  • Histoplasmosis (disseminated or extrapulmonary)
  • Coccidiodomycosis (disseminated or extrapulmonary)
  • Penicilliosis (disseminated or extrapulmonary)
 

31

Conditions

 
  • Sexually transmitted diseases (STDs)
  • Malignant lymphoma
  • Anal carcinoma
  • Anal dysplasia
  • Cervical dysplasia
  • Herpes zoster
  • Hepatitis B (acute or chronic)
  • Hepatitis C (acute or chronic)
  • Mononucleosis-like illness
  • Unexplained leukocytopenia/thrombocytopenia (lasting more than 4 weeks)
  • Seborrheic eczema/dermatitis
  • Invasive pneumococcal disease
  • Unexplained fever
  • Systemic candidiasis
  • Visceral leishmaniasis
  • Pregnancy (due to consequences for the unborn child)
  • Primary lung carcinoma
  • Lymphocytic meningitis
  • Oral hairy leukoplakia
  • Severe or treatment-resistant psoriasis
  • Guillain-Barré syndrome
  • Mononeuritis
  • Subcortical dementia
  • Multiple sclerosis-like disease (MS-like disease)
  • Unexplained peripheral neuropathy
  • Unexplained weight loss
  • Unexplained lymphadenopathy
  • Unexplained candida oris
  • Unexplained chronic diarrhea
  • Unexplained chronic renal failure
  • Hepatitis A
  • Community-acquired pneumonia
  • Candidiasis
  • Conditions in which aggressive immunosuppressive therapy is indicated
    • Cancer
    • Transplants
    • Autoimmune diseases
  • Primary space-occupying process of the brain
  • Idiopathic thrombocytopenic purpura (ITP)
  • Thrombotic thrombocytopenic purpura (TTP)